跳至主要内容
临床试验/NL-OMON30186
NL-OMON30186已完成3 期

Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills - BoBiVa (Botuline toxine Bimanuele Vaardigheden)

Hoensbroek Revalidatiecentrum (HRC)0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • Age 2,5 - 12 years
  • Cerebral Palsy
  • Hagberg diagnosis: spastic hemiparesis or extreme asymmetric diplegia
  • Hand function impairment Zancolli grade I with evident problems in thumb extension and supination, Zancolli grade IIA and IIB (Zancolli E.A., 1987)
  • Mentally able to comprehend and perform tasks
  • Children and their parents should be able to cope with the intensive rehabilitation therapy programme and the measurement sessions
  • Children and the parents/caregivers should comprehend and speak Dutch
  • Children and their parents indicate the necessity for improvement of the children*s abilities

排除标准

  • Severe structural contractures of the muscles at the extremity to be treated (elbow extension deficit 20 degrees, supination deficit 45 degrees, deficit wrist dorsal flexion 30 degrees or more)
  • Severe impairment of hand function, no active hand function is expected after treatment (Zancolli III)
  • Hand surgery, phenolisation or btA injections in the arm less than nine months ago
  • Contra indication for botulinum toxin (children with muscular diseases, like myasthenia gravis, tetanus vaccination less than 3 months before the injection, use of aminoglycoside antibiotics or spectinomycine, known hypersensitivity for human albumin)
  • Contra indication for anaesthesia
  • Children who cannot bare touching the affected arm and hand

研究者

发起方
Hoensbroek Revalidatiecentrum (HRC)

相似试验